5:44 PM
 | 
Feb 26, 2013
 |  BC Extra  |  Company News

FDA approves Shionogi's ospemifene

FDA approved an NDA from Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507) for Osphena ospemifene to treat moderate to severe dyspareunia due to postmenopausal vulvovaginal atrophy. The drug's label includes...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >